175 related articles for article (PubMed ID: 21980426)
1. Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction.
Tang XL; Sanganalmath SK; Sato H; Bi Q; Hunt G; Vincent RJ; Peng Y; Shirk G; Dawn B; Bolli R
PLoS One; 2011; 6(9):e25320. PubMed ID: 21980426
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin improves microenvironment to enhance the beneficial effects of BMSCs therapy in a rabbit model of acute myocardial infarction.
Qu Z; Xu H; Tian Y; Jiang X
Cell Physiol Biochem; 2013; 32(2):380-9. PubMed ID: 23988469
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
4. Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat.
Garjani A; Andalib S; Biabani S; Soraya H; Doustar Y; Garjani A; Maleki-Dizaji N
Eur J Pharmacol; 2011 Sep; 666(1-3):135-41. PubMed ID: 21570962
[TBL] [Abstract][Full Text] [Related]
5. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.
Sola S; Mir MQ; Lerakis S; Tandon N; Khan BV
J Am Coll Cardiol; 2006 Jan; 47(2):332-7. PubMed ID: 16412856
[TBL] [Abstract][Full Text] [Related]
8. Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial.
Post S; Post MC; van den Branden BJ; Eefting FD; Goumans MJ; Stella PR; van Es HW; Wildbergh TX; Rensing BJ; Doevendans PA
Catheter Cardiovasc Interv; 2012 Nov; 80(5):756-65. PubMed ID: 22419603
[TBL] [Abstract][Full Text] [Related]
9. Early administration of Enalapril prevents diastolic dysfunction and ventricular remodeling in rabbits with myocardial infarction.
González GE; Wilensky L; Cassaglia P; Morales C; Gelpi RJ
Cardiovasc Pathol; 2016; 25(3):208-213. PubMed ID: 26897484
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
[TBL] [Abstract][Full Text] [Related]
11. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
12. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin prevents left ventricular remodeling in spontaneously hypertensive rats.
Zhao XY; Li L; Zhang JY; Liu GQ; Chen YL; Yang PL; Liu RY
Int Heart J; 2010; 51(6):426-31. PubMed ID: 21173520
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin administered before myocardial infarction in rats improves contractility irrespective of metabolic changes.
Lehnen TE; Lehnen AM; Tavares AM; Belló-Klein A; Markoski MM; Machado UF; Schaan B
Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):986-94. PubMed ID: 25223307
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats.
Kang L; Ge CJ; Hu SJ
Pharmacology; 2007; 80(2-3):120-6. PubMed ID: 17534121
[TBL] [Abstract][Full Text] [Related]
16. Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction.
Teshima Y; Yufu K; Akioka H; Iwao T; Anan F; Nakagawa M; Yonemochi H; Takahashi N; Hara M; Saikawa T
J Cardiol; 2009 Feb; 53(1):58-64. PubMed ID: 19167639
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin reverses cardiac remodeling possibly through regulation of protein kinase D/myocyte enhancer factor 2D activation in spontaneously hypertensive rats.
Geng J; Zhao Z; Kang W; Wang W; Zhang Y; Zhiming GE
Pharmacol Res; 2010 Jan; 61(1):40-7. PubMed ID: 19683055
[TBL] [Abstract][Full Text] [Related]
18. Effect of atorvastatin on cardiac remodelling and mortality in rats following hyperglycemia and myocardial infarction.
Martin JH; Connelly KA; Boyle A; Kompa A; Zhang Y; Kelly D; Gilbert RE; Krum H
Int J Cardiol; 2010 Sep; 143(3):353-60. PubMed ID: 19395095
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin-induced tolerogenic dendritic cells improve cardiac remodeling by suppressing TLR-4/NF-κB activation after myocardial infarction.
Wang Q; Chen Z; Guo J; Peng X; Zheng Z; Chen H; Liu H; Ma Y; Zhu J
Inflamm Res; 2023 Jan; 72(1):13-25. PubMed ID: 36315279
[TBL] [Abstract][Full Text] [Related]
20. Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction.
Tang XL; Rokosh G; Sanganalmath SK; Tokita Y; Keith MC; Shirk G; Stowers H; Hunt GN; Wu W; Dawn B; Bolli R
Circ Heart Fail; 2015 Jul; 8(4):757-65. PubMed ID: 25995227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
